EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rifampicin and isoniazid resistance not promote fluoroquinolone resistance in Mycobacterium smegmatis

Qin Zhou, Na Pu, Ge Xu, Hangchi Liu, Xudong Jia, Xiaomin Wang, Peng Xu iD

PLOS ONE · 02.01.2025 · 20 (1) · e0315512

DOI: 10.1371/journal.pone.0315512 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 02.01.2025. Verfasst von Qin Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Infectious Diseases, Shenzhen Clinical Research Center for Tuberculosis, Shenzhen Third People's Hospital, Shen…. Hauptthemen laut MEDLINE: Fluoroquinolones, Isoniazid, Mycobacterium smegmatis, Rifampin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Program, Shenzhen High-level Hospital Construction Fund, Shenzhen Clinical Research Center for Tuberculosis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The emergence of drug-resistant Tuberculosis (TB) has made treatment challenging. Although fluoroquinolones (FQs) are used as key drugs in the treatment of multidrug-resistant tuberculosis (MDR-TB), the problem of FQs resistance is becoming increasingly serious. Rifampicin (RIF) resistance is considered a risk factor for FQs resistance. The objective of this study was to investigate the impact of RIF and isoniazid (INH) resistance on the FQs resistance in vitro experiment.

Methods

FQs resistant strains were selected in vitro from RIF and/or INH resistant Mycobacterium smegmatis ( M . sm ). The sequencing of the gyrA gene, and the minimum inhibitory concentration (MIC) of FQs (ciprofloxacin, levofloxacin, moxifloxacin and gatifloxacin) were performed for FQs-resistant strains.

Results

A total of 222 FQs-resistant M . sm strains were selected, all of which had the gyrA mutation. Seven gyrA mutations were detected, with mutations at loci 90 and 94 being the most common. There were no differences in FQs resistance developed from RIF and/or INH resistant M . sm . There was a significant difference in the MIC of the gyrA mutant types to FQs. The highest resistance to FQs was observed in the Gly88Cys mutant strains. M . sm with the identical gyrA mutation showed the highest resistance to ciprofloxacin and relatively low resistance to gatifloxacin and moxifloxacin.

Conclusions

In this study, we found no evidence that RIF and/or INH resistance directly affects FQs resistance in M . sm in vitro experiments. Resistance profiles of different gryA mutations to the four FQs drugs were also presented. These findings provide a more comprehensive understanding of FQs resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluoroquinolonesIsoniazidMycobacterium smegmatisRifampinMicrobial Sensitivity TestsMutationDNA GyraseAntitubercular AgentsDrug Resistance, BacterialDrug Resistance, Multiple, BacterialMoxifloxacin

Substanzen

FluoroquinolonesIsoniazidRifampinDNA GyraseAntitubercular AgentsMoxifloxacin

Autor:innen und Institutionen

  • National Clinical Research Center for Infectious Diseases, Shenzhen Clinical Research Center for Tuberculosis, Shenzhen Third People's Hospital, Shenzhen, Guangdong, China.
  • Zunyi Medical University, Zunyi, Guizhou, China.

ORCID-Profile: Peng Xu

Förderung

  • Shenzhen Science and Technology Program
  • Shenzhen High-level Hospital Construction Fund
  • Shenzhen Clinical Research Center for Tuberculosis
  • National College Students' innovation and entrepreneurship training program
  • Students' innovation and entrepreneurship training program of Guizhou Province

Zitieren

APA

Zhou, Q., Pu, N., Xu, G., Liu, H., Jia, X., Wang, X., & Xu, P. (2025). Rifampicin and isoniazid resistance not promote fluoroquinolone resistance in Mycobacterium smegmatis. PLOS ONE, 20(1), e0315512. https://doi.org/10.1371/journal.pone.0315512

Vancouver

Zhou Q, Pu N, Xu G, Liu H, Jia X, Wang X, et al. Rifampicin and isoniazid resistance not promote fluoroquinolone resistance in Mycobacterium smegmatis. PLOS ONE. 2025;20(1):e0315512. doi:10.1371/journal.pone.0315512

BibTeX
@article{Zhou2025,
  author = {Zhou, Qin and Pu, Na and Xu, Ge and Liu, Hangchi and Jia, Xudong and Wang, Xiaomin and Xu, Peng},
  title = {Rifampicin and isoniazid resistance not promote fluoroquinolone resistance in Mycobacterium smegmatis},
  journal = {PLOS ONE},
  year = {2025},
  volume = {20},
  number = {1},
  pages = {e0315512},
  doi = {10.1371/journal.pone.0315512}
}
Kostenlos starten →